Increases in Incidence Rates of Some Cancers Seen in Early-Onset Age Groups

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, May 15, 2025 -- The incidence rates of 14 cancers have increased in early-onset age groups, with increases in older-onset age groups also occurring in most of these cancers, according to a study published online April 30 in Cancer Discovery.

Meredith S. Shiels, Ph.D., from the National Cancer Institute in Rockville, Maryland, and colleagues examined whether cancer rates have increased at younger ages in the United States by estimating age-standardized cancer incidence (2010 to 2019) and mortality rates (2010 to 2022).

The researchers found that incidence rates increased in at least one early-onset age group (i.e., 15- to 29-, 30- to 39-, and 40- to 49-year-olds) for 14 cancers; nine of these also demonstrated increases in at least one older-onset age group (i.e., 50- to 59-, 60- to 69-, and 70- to 79-year-olds). Compared with expected diagnoses based on 2010 rates, the largest absolute increases in 2019 were female breast, colorectal, kidney, and uterine cancers (4,834; 2,099; 1,793; and 1,209 additional cancers, respectively). For most cancers, there were no concomitant increases in mortality rates, but mortality rates for colorectal, uterine, and testicular cancer increased in early-onset age groups. Drivers of increasing incidence rates were cancer-specific and included a combination of established and novel etiological factors as well as increased detection.

"Descriptive data like these provide a critical starting point for understanding the drivers of rising rates of cancer in early-onset age groups and could translate to effective cancer prevention and early detection efforts," Shiels said in a statement. "As one example, recent guidelines have lowered the age of initiation for breast and colorectal cancer screening based, at least partially, on observations that rates for these cancers are increasing at younger ages."

One author disclosed ties to AbbVie.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-16 12:00

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Increases in Incidence Rates of Some Cancers Seen in Early-Onset Age Groups

Read more

Disclaimer

Popular Keywords